roche_humer

Roche chairman standing down

pharmafile | March 13, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, humer 

The chairman of the Board of directors at Roche, Franz Humer, has announced that he will not stand for re-election to the Board in 2014.

The firm will nominate a successor for the chairmanship in autumn 2013. Roche has decided that Humer’s successor will also serve as non-executive chairman, thus maintaining the established separation of the offices of chairman and chief executive.

Humer said: “Roche is in excellent shape and well positioned to meet future challenges. This is a good time to hand over to a successor. I am looking forward to the next 12 months, and I intend to perform my duties as chairman with enthusiasm and drive.”

Advertisement

Related Content

alzheimers_brain

Roche receives CE Mark for blood test to help rule out Alzheimer’s

Roche has been granted CE Mark approval for its Elecsys pTau181 test, the first in …

blood_test

Roche candidate shows early promise for treating haemophilia A

Roche has announced encouraging early results from its phase 1/2 trial of NXT007, an investigational …

Roche advances treatment for Parkinson’s disease

Swiss biopharma, Roche, has announced its decision to proceed with phase 3 trials of prasinezumab, …

The Gateway to Local Adoption Series

Latest content